Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy.
about
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.Study of the association between CD28/CTLA-4 expression and disease activity in juvenile idiopathic arthritis.Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan.New immunosuppressive agents in pediatric transplantation.
P2860
Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abatacept in the treatment of ...... utility, and place in therapy.
@en
Abatacept in the treatment of ...... utility, and place in therapy.
@nl
type
label
Abatacept in the treatment of ...... utility, and place in therapy.
@en
Abatacept in the treatment of ...... utility, and place in therapy.
@nl
prefLabel
Abatacept in the treatment of ...... utility, and place in therapy.
@en
Abatacept in the treatment of ...... utility, and place in therapy.
@nl
P2860
P921
P356
P1476
Abatacept in the treatment of ...... utility, and place in therapy.
@en
P2093
Ofra Goldzweig
Philip J Hashkes
P2860
P356
10.2147/DDDT.S16489
P407
P577
2011-01-26T00:00:00Z